Lupeol anti-tumor agent and uses thereof

Abstract

Methods for the prevention, treatment and/or alleviation of skin disorders and skin cancers, and for the prevention, treatment and/or alleviation of prostate cancer and pancreatic cancer by administering a Lupeol-derived anti-tumor compound are disclosed. Pharmaceutical and nutraceutical compositions containing Lupeol-derived anti-tumor compounds are also disclosed.

What is claimed is: 
     
         1 . A method of treating prostate cancer comprising administering to a human in need thereof a therapeutically effective amount of a composition comprising a compound having the formula: 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof, 
       
       wherein the compound treats prostate cancer in a dose dependent manner. 
     
     
         2 . The method of  claim 1 , wherein the composition is administered to the subject by oral, topical, nasal, pulmonary, or parenteral delivery. 
     
     
         3 . The method of  claim 2 , wherein the composition is administered to the subject orally. 
     
     
         4 . The method according to  claim 1 , wherein the composition is administered to the subject parenterally, paracancerally, transmucosally, transdermally, intramuscularly, intravenously, intradermally, subcutaneously, intraperitoneally, intraventricularly, intracranially, or intratumorally.